A metabolomics study pinpointed the differences between leukemia stem cells (LSCs) and their normal counterparts, and suggests elevated levels of spermidine are a signature and a targetable weakness in LSCs.

Spermidine is essential for the function of leukemia stem and progenitor cells through the regulation of KAT7 expression.